regional pheochromocytoma
Showing 1 - 25 of 3,272
Locally Advanced Paraganglioma, Metastatic Adrenal Gland Pheochromocytoma, Metastatic Paraganglioma Trial in Houston
Recruiting
- Locally Advanced Paraganglioma
- +5 more
- Cabozantinib S-malate
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Jun 7, 2021
Advanced Adrenal Gland Pheochromocytoma, Advanced Paraganglioma, Metastatic Adrenal Gland Pheochromocytoma Trial in United
Recruiting
- Advanced Adrenal Gland Pheochromocytoma
- +5 more
- Olaparib
- +2 more
-
Anchorage, Alaska
- +153 more
Aug 23, 2022
Malignant Solid Tumor, Recurrent Adrenal Gland Pheochromocytoma, Recurrent Ectomesenchymoma Trial in Puerto Rico, United States
Recruiting
- Malignant Solid Neoplasm
- +40 more
- Biospecimen Collection
- +6 more
-
Birmingham, Alabama
- +172 more
Jan 27, 2023
Acinar Cell Carcinoma, Adenoid Cystic Carcinoma, Adrenal Cortical Carcinoma Trial in Guam, United States (Biospecimen
Recruiting
- Acinar Cell Carcinoma
- +93 more
- Biospecimen Collection
- +2 more
-
Birmingham, Alabama
- +998 more
Aug 23, 2022
Intraoperative Hemodynamic Instability During Unilateral
Recruiting
- Pheochromocytoma
- Non-Secretory Adrenal Adenoma
- adrenalectomy
-
Nancy, FranceCHRU Nancy - Département Chirurgie Viscérale, Métabolique et Can
Sep 25, 2023
Pheochromocytoma Trial in Seoul (dexmedetomidine, 0.9% normal saline)
Completed
- Pheochromocytoma
- dexmedetomidine
- 0.9% normal saline
-
Seoul, Korea, Republic ofSeverance hospital
Sep 12, 2023
Adrenal Pheochromocytoma, Hemodynamic Trial (Abandonment of intravenous volume expansion during preoperative preparation in
Completed
- Adrenal Pheochromocytoma
- Hemodynamic
- Abandonment of intravenous volume expansion during preoperative preparation in patients with pheochromocytoma
- (no location specified)
Mar 25, 2023
Pheochromocytoma, Endocrine Disease, Endocrine Diseases Trial run by the Eunice Kennedy Shriver National Institute of Child
Recruiting
- Pheochromocytoma
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 18, 2023
Pheochromocytoma, Paraganglioma Trial in New York (Axitinib)
Recruiting
- Pheochromocytoma
- Paraganglioma
-
New York, New YorkColumbia University Irving Medical Center
Oct 5, 2022
I Hemodynamic Instability and Conversion in Adrenalectomy for
Completed
- adrenalDisease
- laparoscopic adrenalectomy
- (no location specified)
Sep 26, 2023
VHL Pancreatic Neuroendocrine Tumors, Von Hippel-Lindau Disease, Neuroendocrine Tumors Trial run by the National Cancer
Recruiting
- VHL Pancreatic Neuroendocrine Tumors
- +2 more
- 68-Gallium DOTATATE
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 26, 2023
Anlotinib Treatment Response Using Contrast Enhanced Ultrasound
Recruiting
- Pheochromocytoma, Metastatic
- +3 more
- Contrast-enhanced ultrasound(CEUS)
-
Beijing, ChinaPeking Union Medical College Hospital
Aug 28, 2023
Pheochromocytoma, Paraganglioma Trial in Beijing (Anlotinib HCl)
Recruiting
- Pheochromocytoma
- Paraganglioma
- Anlotinib hydrochloride
-
Beijing, ChinaPeking Union Medical College Hospital
May 22, 2023
Pheochromocytoma, Paraganglioma, Inherited Cancer Syndrome Trial in San Antonio (Genetic screening)
Recruiting
- Pheochromocytoma
- +7 more
- Genetic screening
-
San Antonio, TexasUniversity of Texas Health Science Center
Aug 25, 2022
Pheochromocytoma, Paraganglioma Trial in Beijing (Temozolomide)
Recruiting
- Pheochromocytoma
- Paraganglioma
-
Beijing, ChinaPeking Union Medical College Hospital
May 22, 2023
Genetic Factors and Pheochromocytomas in Neoplasia Type 2
Recruiting
- Neoplasia
- Pheochromocytoma
-
Marseille, FranceAPHM - Hôpital de la Conception
Jan 30, 2022
Pheochromocytoma, Metastatic, Pheochromocytoma Malignant, Paraganglioma, Malignant Trial in Beijing (Penpulimab)
Recruiting
- Pheochromocytoma, Metastatic
- +2 more
-
Beijing, ChinaPeking Union Medical College Hospital
May 31, 2023
Pheochromocytoma, Paraganglioma Trial in Philadelphia ([18F]FluorThanatrace ([18F]FTT))
Not yet recruiting
- Pheochromocytoma
- Paraganglioma
- [18F]FluorThanatrace ([18F]FTT)
-
Philadelphia, PennsylvaniaAbramson Cancer Center of the University of Pennsylvania
Dec 1, 2022
Malignant Adrenal Gland Pheochromocytoma, Malignant Paraganglioma, Metastatic Adrenal Gland Pheochromocytoma Trial in Rochester
Completed
- Malignant Adrenal Gland Pheochromocytoma
- +2 more
- Laboratory Biomarker Analysis
- +2 more
-
Rochester, MinnesotaMayo Clinic
Sep 28, 2022
Pheochromocytoma, Metastatic, Paraganglioma, Malignant, Pheochromocytoma Malignant Trial in Beijing (Temozolomide capsule)
Completed
- Pheochromocytoma, Metastatic
- +2 more
- Temozolomide capsule
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
May 4, 2023
Pheochromocytoma/Paraganglioma, Pancreatic Neuroendocrine Tumor, Von Hippel-Lindau Disease Trial in Worldwide (Belzutifan)
Recruiting
- Pheochromocytoma/Paraganglioma
- +2 more
-
Los Angeles, California
- +58 more
Jan 27, 2023
Magnesium and Dexmedetomidine in Pheochromocytoma
Completed
- Phaeochromocytoma Crisis
- Hemodynamic Instability
- (no location specified)
Oct 20, 2021
PGL Trial in Beijing
Recruiting
- PGL
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital,Chinese Academy of Medical
Mar 6, 2023
Neuroblastoma, Pheochromocytoma Trial in Memphis (18F-DA)
Recruiting
- Neuroblastoma
- Pheochromocytoma
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Feb 15, 2022